If you searched for a Vyvanse patient assistance program because the cost of your prescription is a real problem, you've probably already found conflicting answers. Some sites still say Takeda gives away free brand Vyvanse to anyone under a certain income. Others don't mention it at all. That inconsistency isn't your imagination — it's because the program genuinely changed, and a lot of the content still circulating online was written before that happened.
We checked Takeda's own Help at Hand eligibility tool and product list directly for this guide. As of 2026, Vyvanse is not on it. This page explains exactly what that means, why it happened, and — more usefully — every real path that's still open to you if the cost of Vyvanse or its generic is a barrier to treatment.
What Happened to the Vyvanse Patient Assistance Program
Takeda's Help at Hand program has offered free or reduced-cost medication to qualifying uninsured and underinsured patients since 2008. For years, brand Vyvanse was part of that list, and older articles, PDFs, and forum threads about a "Vyvanse patient assistance program" are referring to that era.
That's no longer the case. Takeda's current Help at Hand product page lists only these medications: DEXILANT, EOHILIA, FOSRENOL, INTUNIV, LIALDA, PENTASA, PREVACID SOLUTAB, ROZEREM, and TRINTELLIX. Vyvanse does not appear anywhere on that list, and running Vyvanse through the program's own eligibility checker doesn't return it as a selectable product.
| Status | Earlier Years | 2026 |
|---|---|---|
| On Takeda Help at Hand product list | Yes | No |
| Generic lisdexamfetamine available | No | Yes (since August 2023) |
| Takeda commercial copay savings card | Yes | Yes, unchanged |
| Income-based free brand Vyvanse from Takeda | Yes, for qualifying patients | No longer offered |
If a site tells you to "apply for the Vyvanse Help at Hand program," be skeptical. Some patient-assistance directories and paid navigator services haven't updated their pages. Always confirm directly at Takeda's own Help at Hand site before spending time gathering documents for an application.
Why Takeda Removed Vyvanse From Help at Hand
Manufacturer patient assistance programs exist to get brand medication into the hands of people who otherwise couldn't afford it. Almost every one of these programs — Takeda's included — is built around a core rule: assistance is generally reserved for drugs that don't have an approved, widely available generic equivalent. Once a generic exists, the manufacturer's position is that patients have a much cheaper path to the same active ingredient, so the free-brand program is no longer the right tool.
The FDA approved the first generic lisdexamfetamine dimesylate capsules in August 2023, cleared for multiple manufacturers. Within about six months, cash prices for the generic at major pharmacy chains had dropped well below brand pricing, and pharmacy benefit managers quickly moved the generic to preferred formulary tiers while shifting brand Vyvanse to non-preferred or specialty tiers. That combination — a cheap generic plus insurers steering patients toward it — is exactly the scenario that typically ends a brand's manufacturer assistance eligibility.
Why this matters for you: This isn't a sign that Takeda is cutting support for patients broadly. It's the same lifecycle nearly every brand drug goes through once a generic launches. The practical upside is that generic lisdexamfetamine, even without any assistance program, is usually cheaper than brand Vyvanse ever was through Help at Hand's out-of-pocket alternative.
Is There Any Way to Get Vyvanse Free or Low-Cost in 2026?
Yes — just not through a Takeda income-based grant of free brand Vyvanse. Here's every legitimate route still open, compared side by side.
| Option | Best For | Typical Cost |
|---|---|---|
| Generic lisdexamfetamine + discount card | Uninsured or cash-paying patients | $68–$150/month at many pharmacies (see the Vyvanse cost guide) |
| Takeda Vyvanse copay savings card | Commercially insured patients prescribed brand | As low as $30/month, capped annually |
| Medicare Extra Help (Part D LIS) | Low-income Medicare beneficiaries | Reduced Part D premiums, deductibles, copays |
| Medicaid formulary coverage | Medicaid enrollees (often needs prior auth) | Usually a small state-set copay or $0 |
| 340B community health centers | Patients receiving care at a qualifying clinic | Sliding scale, income-dependent |
| State Pharmaceutical Assistance Program (SPAP) | Residents of states that run one | Varies widely by state |
| Takeda Help at Hand (Vyvanse specifically) | No one — not currently offered for this drug | Not available |
If cost is only part of the problem and stock is the other, check our 2026 Vyvanse shortage guide for what's currently affected and how to track down a fill. And if you want a full cash-price breakdown before comparing pharmacies, our Vyvanse cost without insurance guide covers brand and generic pricing in detail.
Eligibility Comparison: Who Qualifies for What
| Program | Covers | Insurance Required? | Income-Based? |
|---|---|---|---|
| Takeda Vyvanse savings card | Brand only | Commercial insurance required | No |
| GoodRx / SingleCare discount cards | Generic (best pricing), some brand | No — cannot combine with insurance | No |
| Medicare Extra Help (LIS) | Whatever your Part D plan covers | Must be enrolled in Part D | Yes |
| State Medicaid | Generic; brand with prior auth in some states | Medicaid enrollment required | Yes |
| 340B / community health centers | Both, sliding scale | No insurance required | Yes |
| NeedyMeds / RxAssist directories | Points to whatever programs currently exist | Varies by matched program | Depends |
Manufacturer copay cards and government insurance don't mix. If you have Medicare, Medicaid, or TRICARE, federal anti-kickback rules block you from using Takeda's commercial copay card — regardless of income. Your realistic options in that case are Extra Help, your plan's formulary, or a cash-price discount card compared against your copay.
Income Limit Comparison Across Programs
Because Vyvanse itself no longer has an income-based manufacturer program, the income thresholds that matter now come from the programs listed above, not from Takeda. Here's how they compare using the 2026 Federal Poverty Level of $33,000 for a family of four in the 48 contiguous states.
| Program | Income Threshold | Approx. Annual Income (Family of 4) |
|---|---|---|
| Medicare Extra Help — full subsidy | ~135–150% FPL + resource limit | ~$44,550–$49,500 |
| Medicare Extra Help — partial subsidy | Up to ~150% FPL, sliding scale | Up to ~$49,500 |
| Medicaid (varies by state) | Often 138%–200% FPL for adults | ~$45,540–$66,000 |
| Takeda Help at Hand (other Takeda drugs, not Vyvanse) | Up to 500% FPL | Up to ~$165,000 |
| 340B sliding-scale clinics | Clinic-specific, often up to 200% FPL for the deepest discount | Up to ~$66,000 |
That Takeda row is worth noticing: other Help at Hand medications, like INTUNIV, still use a generous income ceiling of up to five times the poverty level. It's not that Takeda tightened its rules across the board — Vyvanse specifically was removed because of the generic, not because the company narrowed its income policy.
Covered Medications: Brand vs. Generic Support
| Medication | Manufacturer PAP | Manufacturer Copay Card | Discount Card Pricing | Medicare/Medicaid |
|---|---|---|---|---|
| Brand Vyvanse (Takeda) | Not offered | Yes (commercial only) | Available, usually higher than generic | Plan-dependent, often non-preferred tier |
| Generic lisdexamfetamine (multiple makers) | Generics rarely have manufacturer PAPs | Not applicable to generics | Yes — typically the lowest price | Usually preferred tier / low copay |
| INTUNIV (guanfacine ER, Takeda) | Still offered via Help at Hand | Check current terms | Generic guanfacine widely available | Usually covered |
The pattern holds across most ADHD medications: once a generic is well established, expect the brand's manufacturer assistance program to disappear while manufacturer copay cards (for the insured) tend to stick around longer.
Step-by-Step: How to Get Help Paying for Vyvanse or Generic Lisdexamfetamine
Ask your prescriber about the generic
Generic lisdexamfetamine is FDA-rated as therapeutically equivalent to brand Vyvanse. Unless there's a specific clinical reason to stay on brand, switching is usually the single biggest cost reduction available to you.
Price the generic with a free discount card before you fill
Compare your insurance copay against a cash price using GoodRx or SingleCare at two or three nearby pharmacies. Prices for the same generic can differ by well over $100 a month between pharmacies in the same city.
If you're commercially insured and staying on brand, enroll in Takeda's savings card
See our full Vyvanse savings card guide for current terms, annual caps, and how to enroll — it can meaningfully cut your copay if brand Vyvanse is medically necessary for you.
If you're on Medicare or Medicaid, check income-based subsidies
Apply for Medicare Extra Help if your income and resources are limited, or confirm how your state's Medicaid formulary handles lisdexamfetamine. Our Medicare Extra Help (LIS) guide and Medicare Part D explainer walk through both.
If you're uninsured and still can't afford it, search independent directories
NeedyMeds and RxAssist maintain searchable databases of state programs, charitable funds, and discount cards that change over time. They won't manufacture a Vyvanse-specific PAP that doesn't exist, but they may surface a state or nonprofit option you haven't tried.
Ask about a 340B clinic near you
Federally Qualified Health Centers and other 340B-participating providers often offer sliding-scale pricing on both brand and generic medications based on household income, independent of any manufacturer program.
Decision Tree: What Should You Do Right Now?
Are you currently on brand Vyvanse or generic lisdexamfetamine?
This determines which savings path actually applies to you
Do you have commercial insurance?
If yes, enroll in Takeda's Vyvanse savings card
If no insurance
Ask your prescriber about switching to generic before assuming brand is your only option
Are you insured?
Compare your copay against a discount-card cash price every fill
If uninsured
Use a discount card, check 340B clinics, or look into a state SPAP
Still can't afford it?
Apply for Medicare Extra Help or Medicaid if eligible, and ask your prescriber about non-stimulant alternatives like generic atomoxetine
Application Process for Each Option
| Program | How to Apply |
|---|---|
| Takeda Vyvanse savings card | Enroll online or through your pharmacy at the point of sale; no income documentation needed |
| GoodRx / SingleCare | Free sign-up online or via app; present the coupon or card at the pharmacy counter |
| Medicare Extra Help | Apply through the Social Security Administration online, by phone, or in person |
| Medicaid | Apply through your state Medicaid agency or Healthcare.gov if you're not yet enrolled |
| 340B community health center | Schedule an appointment at a qualifying clinic and ask about their sliding-fee scale |
| NeedyMeds / RxAssist | Search by drug name on their websites; each matched program has its own application |
Never pay an upfront fee to "apply" for a manufacturer savings card. Takeda's own copay card is free to enroll in directly. If a third-party service asks for payment before connecting you to a manufacturer program, treat that as a red flag.
Approval and Processing Timelines
| Program | Typical Timeline |
|---|---|
| Takeda Vyvanse savings card | Instant at enrollment; active same-day at most pharmacies |
| Discount cards (GoodRx, SingleCare) | Instant; no waiting period |
| Medicare Extra Help | Typically decided within about 30 days of a complete application |
| Medicaid enrollment | Varies by state; often 15–45 days for a full application |
| 340B clinic sliding-scale approval | Often same-visit once income documentation is reviewed |
Renewing or Reapplying for Assistance
- Takeda's savings card generally requires re-enrollment or reactivation once its annual benefit cap resets — check current terms in our Vyvanse savings card guide.
- Medicare Extra Help eligibility is reviewed annually by Social Security; you may need to reapply if your income or resources change.
- Medicaid requires periodic redetermination, typically annually, to confirm continued eligibility.
- Discount cards like GoodRx don't expire or require renewal — the price simply updates automatically.
- Since Takeda's product list can change at any time, it's worth rechecking Help at Hand every year or two in case Vyvanse policy shifts again.
Pros and Cons of Each Path
Pros
- Generic lisdexamfetamine with a discount card is often cheaper than brand Vyvanse ever was, even accounting for the old assistance program
- Takeda's copay card requires no income documentation, so it's fast for insured patients on brand
- Medicare and Medicaid income-based support exists independent of whatever Takeda decides to do with Vyvanse
- Discount cards can be combined with pharmacy-specific savings clubs for even lower prices
Cons
- Uninsured patients who specifically need brand Vyvanse (rather than generic) no longer have a free option through Takeda
- Manufacturer copay cards can't be used with any government insurance, which rules out a large share of patients
- Intermittent stimulant shortages can make even a well-planned savings strategy pointless if the pharmacy has no stock
- Some third-party "assistance finder" services charge fees for matching you to programs you could apply to yourself for free
Common Mistakes That Cost Patients Money
- Assuming an older article's description of the Vyvanse patient assistance program is still accurate in 2026.
- Trying to use a manufacturer copay card while enrolled in Medicare, Medicaid, or TRICARE — it will be rejected at the pharmacy.
- Paying full brand-name cash price without ever pricing the generic with a free discount card first.
- Assuming your insurance copay is automatically cheaper than a cash discount-card price — it often isn't, especially before meeting a deductible.
- Giving payment information to a "patient assistance" service before confirming the underlying program actually exists and is free to apply to directly.
- Not checking pharmacy stock at more than one location during a shortage before assuming Vyvanse or its generic is unavailable everywhere.
Real Examples: How Patients Are Handling This
Example 1 — Uninsured adult, previously on brand: A patient who used to qualify for free brand Vyvanse through Help at Hand loses that option when the drug is removed from the list. Their prescriber switches them to generic lisdexamfetamine, and a GoodRx coupon brings the monthly cost down to roughly $70 — lower than many patients paid even with the old brand program's copay tier.
Example 2 — Commercially insured, needs brand for medical reasons: A patient whose formulary places brand Vyvanse on a high copay tier, and whose doctor documents a clinical reason generic switching isn't appropriate, enrolls in Takeda's copay savings card and brings their monthly cost down substantially, capped by the program's annual limit.
Example 3 — Medicare beneficiary on a fixed income: A retiree on Medicare Part D with limited income and resources applies for Extra Help through Social Security. Once approved, their Part D plan's copay for generic lisdexamfetamine drops to a small, predictable amount each month — independent of anything happening with Takeda's brand program.
Vyvanse vs. Other ADHD Medication Assistance
It's worth zooming out, because the Vyvanse situation isn't unique — it reflects how manufacturer assistance generally works once a generic launches.
| Medication | Generic Available? | Manufacturer PAP Status |
|---|---|---|
| Vyvanse (lisdexamfetamine) | Yes, since 2023 | Not offered |
| INTUNIV (guanfacine) | Yes | Still offered via Takeda Help at Hand |
| Adderall XR / generic amphetamine salts | Yes, widely | Generally not offered |
| Concerta / generic methylphenidate ER | Yes, widely | Generally not offered |
If your household relies on more than one prescription and you want to know whether a specific drug still has manufacturer support, don't rely on general "ADHD assistance" roundups — check that manufacturer's current eligibility tool directly, the same way we did for this guide.
Bottom Line
Vyvanse's manufacturer patient assistance program is gone, and it isn't coming back unless the generic landscape changes dramatically. That's a real shift from a few years ago, but it isn't the dead end it might feel like. Generic lisdexamfetamine with a free discount card is often cheaper than brand Vyvanse ever was, and commercially insured, Medicare, and Medicaid patients each have separate, still-active support paths that don't depend on Takeda at all.
The fastest way to lower your cost is usually the simplest: confirm with your prescriber whether generic is appropriate for you, price it against your insurance copay, and only pursue brand-specific programs if there's a genuine clinical reason to stay on brand Vyvanse.